Provayblue Injection
Product Images NDC 0517-0374

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Provayblue (NDC 0517-0374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ampule 2ml

This is a description for a medication called RovayBlue® injection USP that has NDC number 0517-0125-01 and lot number 28064188. The medication is intended for intravenous use only and comes in a single-dose ampule that should be discarded if unused. The medication should be used with 5% Dextrose Injection, and it contains ethylene blue. It was manufactured by CENEXI for PROVEPHARM SAS and distributed by AMERICAN REGENT, INC. in Shirley, NY. The text also includes a revision date of 12/2021.*

FDA Label Image

Carton 10ml

ProvayBlue is a single-dose methylene blue injection used for slow intravenous injection. The injection has a strength of 50 mg/10 mL (5 mg/mL) and should be diluted with 5% Dextrose Injection. The solution comes in single-dose ampules that should be discarded if not used. The manufacturer of ProvayBlue is CEDEX, located in France. The NDC number is 0517-0374-05. No other useful information can be obtained from the given text obtained by .*

FDA Label Image

Carton 2ml

ProvayBlue (methylene blue) Injection USP is a patented intravenous medication designed to be used for slow intravenous injection. It is distributed by American Provepharm and manufactured by Cenext in France. The package provides specific instructions for the use of 5% Dextrose for injection to dilute the medication. The NDC code is 0517-0125-05.*

FDA Label Image

Cartonvial 10ml

This is a medication called Methylene Blue that is administered through injection. Each 10 mL vial contains 50 mg of Methylene Blue. It's an intravenous drug only and should only be used as directed by a physician. The medication should not be refrigerated or frozen and should be stored in the original package, protected from light, and at 20°C to 25°C (68°F to 77°F). Once opened, any remaining solution should be discarded. The full prescribing information is available in the package insert. The medication is distributed by American Regent Inc. and manufactured by Cenexi HSC Provepharm SAS.*

FDA Label Image

Cartonvial 2ml

FDA Label Image

Label 10ml

ProvayBlue is an injection of 50mg/10mL methylene blue, intended for intravenous use only. It is recommended to dilute this medication with 5% Dextrose Injection. This product comes in a single dose ampule, with unused portions needing to be discarded. It is manufactured by CENEXI for PROVEPHARM SAS and distributed by AMERICAN REGENT, INC. The lot mentioned on this label is NDC 0517-0374-01 and the revision date is 12th December 2021.*

FDA Label Image

Figure (Pro0d 0004 01)

FDA Label Image

Vial 10ml

ProvayBlue® (methylene blue) Injection USP is a medication used for intravenous use only. Each single dose vial contains 50 mg of the active ingredient and should be diluted with 5% Dextrose in Water. The lot number and expiration date are printed on the label, and any unused portion should be discarded. This medication is manufactured by CENEXI for PROVEPHARM SAS and distributed by AMERICAN REGENT, INC. in Shirley, NY.*

FDA Label Image

Vial 2ml

The text appears to be a description of a medical product called S ProvcyBlue, which is an intravenous injection containing methylene blue. The product comes in a 10 mg/2 mL concentration and is used for various purposes. The text also includes instructions for diluting the product with water, as well as information about how to properly dispose of any unused portions. The lot number and expiration date are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.